Abstract
In the western part of the world, cancer in the colon and the
rectum is the third most common cancer with an incidence of
1.4 million new cases in 2012 [1]. Accordingly, the number of
colonoscopies performed on suspicion of cancer is large and
because of the initiation of screening programs for blood in the
stool also increasing. The screening programs for #colorectal cancer
have downgraded the majority of the tumors found from the
cancer stages T3-4 to T1-2 [2,3]. And thus increased the number
of potentially #endoscopically removable T1 tumors. In addition, the
demography of the population is changing, with a greater number
of elderly patients with greater probability of having co-existing
diseases. The medical co-existing diseases play a major role in the
risk of adverse outcomes including death following the surgical
resection of the colon or the rectum irrespective the procedure
is performed #laparoscopically or by open surgery [4-6]. At the
same time, #endoscopist’s are becoming increasingly skilled in the
removal of large colorectal polyps by the technique of endoscopic
mucosa resection (EMR) or endoscopic #mucosa dissection (ESD).
Is it Time to Revise the Treatment of Early #Colorectal Cancers? A #Danish Point of View by Birgitte Brandstrup in BJSTR
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.